177Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90 inhibition.
Hofving T, Sandblom V, Arvidsson Y, Shubbar E, Altiparmak G, Swanpalmer J, Almobarak B, Elf AK, Johanson V, Elias E, Kristiansson E, Forssell-Aronsson E, Nilsson O.
Hofving T, et al. Among authors: sandblom v.
Endocr Relat Cancer. 2019 Apr 1;26(4):437-449. doi: 10.1530/ERC-18-0509. Epub 2019 Feb 1.
Endocr Relat Cancer. 2019.
PMID: 30730850
Free PMC article.